- Home
- ARVN vs SEAT Comparison
ARVN vs SEAT Comparison
Compare ARVN & SEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- SEAT
- Stock Information
- Founded
- ARVN 2015
- SEAT 2001
- Country
- ARVN United States
- SEAT United States
- Employees
- ARVN N/A
- SEAT N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- SEAT Industrial Machinery/Components
- Sector
- ARVN Health Care
- SEAT Industrials
- Exchange
- ARVN Nasdaq
- SEAT Nasdaq
- Market Cap
- ARVN 456.2M
- SEAT 366.2M
- IPO Year
- ARVN 2018
- SEAT N/A
- Fundamental
- Price
- ARVN $7.90
- SEAT $15.48
- Analyst Decision
- ARVN Buy
- SEAT Buy
- Analyst Count
- ARVN 22
- SEAT 11
- Target Price
- ARVN $20.21
- SEAT $68.00
- AVG Volume (30 Days)
- ARVN 1.8M
- SEAT 274.9K
- Earning Date
- ARVN 10-29-2025
- SEAT 08-05-2025
- Dividend Yield
- ARVN N/A
- SEAT N/A
- EPS Growth
- ARVN N/A
- SEAT N/A
- EPS
- ARVN N/A
- SEAT N/A
- Revenue
- ARVN $372,800,000.00
- SEAT $694,007,000.00
- Revenue This Year
- ARVN $4.87
- SEAT N/A
- Revenue Next Year
- ARVN N/A
- SEAT N/A
- P/E Ratio
- ARVN N/A
- SEAT N/A
- Revenue Growth
- ARVN 299.57
- SEAT N/A
- 52 Week Low
- ARVN $5.90
- SEAT $15.13
- 52 Week High
- ARVN $29.61
- SEAT $100.00
- Technical
- Relative Strength Index (RSI)
- ARVN 60.55
- SEAT 31.72
- Support Level
- ARVN $7.62
- SEAT $16.58
- Resistance Level
- ARVN $8.22
- SEAT $18.01
- Average True Range (ATR)
- ARVN 0.31
- SEAT 1.01
- MACD
- ARVN 0.10
- SEAT 0.55
- Stochastic Oscillator
- ARVN 76.98
- SEAT 10.65
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About SEAT Vivid Seats Inc.
Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.